Voyager Therapeutics (VYGR) Reports Q3 Revenues Beat; Revenues 'Up Over 16x' from 2Q21

Go back to Voyager Therapeutics (VYGR) Reports Q3 Revenues Beat; Revenues 'Up Over 16x' from 2Q21
(NASDAQ: VYGR) Delayed: 3.32 -0.11 (3.21%)
Previous Close $3.43    52 Week High $30.54 
Open $3.40    52 Week Low $8.12 
Day High $3.51    P/E N/A 
Day Low $3.31    EPS $0.00 
Volume 395,780